GeneMedicine
PrivateLast Round
Series C
May 20, 2025
Total Funding Raised
$40.7M
Company Overview
GeneMedicine operates in Healthcare & Life Sciences and is based in Seoul. Its latest recorded funding round was a Series B round in July 2021.
GeneMedicine is a biotechnology company that develops oncolytic virus and gene therapeutic platforms for the treatment of intractable cancers.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting, Data as a Service
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
GeneMedicine Comparables
Compare GeneMedicine with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Lokon Pharma | 81% | |
| Valo Therapeutics | 81% | |
| TILT Biotherapeutics | 80% |
For institutional investors. Book with your work email.
GeneMedicine Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series C | May 20, 2025 | ||||
| Series B | Jul 1, 2021 | ||||
| Series A | May 1, 2019 | ||||
| Seed | Dec 1, 2018 | ||||
| Corporate Funding | Jul 1, 2016 |
For institutional investors. Book with your work email.
GeneMedicine Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Bluepoint Partners | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 18, 2026
Monthly visitors increased 143% MoM, reaching 2.9K.
- Apr 3, 2026
Monthly visitors increased 31% MoM.
For institutional investors. Book with your work email.
GeneMedicine Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about GeneMedicine's valuation, stock price, and market status.
Is GeneMedicine a public or private company?
GeneMedicine is a private company.
What is the current stock price of GeneMedicine?
GeneMedicine is a private company, so its shares have no public market price. Caplight tracks GeneMedicine's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is GeneMedicine worth (valuation)?
Valuation information for GeneMedicine is not publicly available.
Can I buy GeneMedicine stock?
GeneMedicine shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was GeneMedicine's last funding round?
GeneMedicine's most recent funding round was Series C on May 20, 2025.
Who are the main investors in GeneMedicine?
Key investors in GeneMedicine include Bluepoint Partners.
Will GeneMedicine IPO soon?
No public IPO plans have been announced for GeneMedicine.
How can I track GeneMedicine secondary market activity?
Caplight tracks bids, offers, and trades in GeneMedicine's shares on secondary markets.